Abstract Background There is no disease-specific instrument to assess health-related quality of life (HRQL) in patients with idiopathic pulmonary fibrosis (IPF). Methods Patients' perspectives were collected to develop domains and items for an IPF-specific HRQL instrument. We used item variance and Rasch analysis to construct the ATAQ-IPF (A Tool to Assess Quality of life in IPF). Results The ATAQ-IPF version 1 is composed of 74 items comprising 13 domains. All items fit the Rasch model. Domains and the total instrument possess acceptable psychometric characteristics for a multidimensional questionnaire. The pattern of correlations between ATAQ-IPF scores and physiologic variables known to be important in IPF, along with significant differe...
Background: Predicting the survival of patients with Idiopathic pulmonary fibrosis (IPF) remains cha...
Idiopathic pulmonary fibrosis (IPF) is a devastating, progressive and ultimately fatal lung disease....
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a rare disease with a median survival of ...
Idiopathic pulmonary fibrosis (IPF) is one of the most common forms of interstitial lungdisease pres...
AbstractMany studies conducted on the health status and quality of life (QOL) of patients with certa...
Abstract Background The INSIGHTS-IPF registry provides one of the largest data sets of clinical data...
BackgroundIdiopathic pulmonary fibrosis (IPF) is a debilitating lung disease with a survival of only...
Idiopathic pulmonary fibrosis (IPF) is one of the most common forms of interstitial lung disease pre...
Rationale: The A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF) was deve...
BACKGROUND: Few studies have investigated the relationship between physiological outcomes and qualit...
SummaryThe prognosis of patients with idiopathic pulmonary fibrosis (IPF) is generally considered to...
Background and objective:Studies analysing the effect of worsening pulmonary physiological impairmen...
Introduction: The PROOF registry is a prospective, observational study that aimed to monitor disease...
Background and objective: Studies analysing the effect of worsening pulmonary physiological impairme...
Background: Predicting the survival of patients with Idiopathic pulmonary fibrosis (IPF) remains cha...
Idiopathic pulmonary fibrosis (IPF) is a devastating, progressive and ultimately fatal lung disease....
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a rare disease with a median survival of ...
Idiopathic pulmonary fibrosis (IPF) is one of the most common forms of interstitial lungdisease pres...
AbstractMany studies conducted on the health status and quality of life (QOL) of patients with certa...
Abstract Background The INSIGHTS-IPF registry provides one of the largest data sets of clinical data...
BackgroundIdiopathic pulmonary fibrosis (IPF) is a debilitating lung disease with a survival of only...
Idiopathic pulmonary fibrosis (IPF) is one of the most common forms of interstitial lung disease pre...
Rationale: The A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF) was deve...
BACKGROUND: Few studies have investigated the relationship between physiological outcomes and qualit...
SummaryThe prognosis of patients with idiopathic pulmonary fibrosis (IPF) is generally considered to...
Background and objective:Studies analysing the effect of worsening pulmonary physiological impairmen...
Introduction: The PROOF registry is a prospective, observational study that aimed to monitor disease...
Background and objective: Studies analysing the effect of worsening pulmonary physiological impairme...
Background: Predicting the survival of patients with Idiopathic pulmonary fibrosis (IPF) remains cha...
Idiopathic pulmonary fibrosis (IPF) is a devastating, progressive and ultimately fatal lung disease....
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a rare disease with a median survival of ...